Holobiome, Inc.
Biotechnology company · Boston, Massachusetts, United States
Holobiome, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.9 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $6.6 million sold in a notice filed in 2024.
Holobiome at a glance
What does Holobiome do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $1.9 million in total (2019 to 2021). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $6.6 million sold (2024).
Frequently asked questions about Holobiome
Where is Holobiome headquartered?
Holobiome, Inc. is headquartered in Boston, Massachusetts, United States.
What does Holobiome do?
Holobiome, Inc. is a biotechnology company.
When was Holobiome founded?
The earliest incorporation on record for Holobiome, Inc. is in 2015, according to public company registers.
Similar companies
- Elucid Bioimaging Inc.Boston, Massachusetts, United States
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
- Odyssey Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.